One‐year outcomes of the ARTISAN‐SNM study with the Axonics System for the treatment of urinary urgency incontinence
暂无分享,去创建一个
B. Blok | C. Comiter | H. Goldman | U. Lee | M. Kennelly | S. de Wachter | K. Peters | P. V. van Kerrebroeck | M. Perrouin-Verbe | F. Lane | R. McCrery | J. Mangel | M. Pakzad | K. Benson | J. Gruenenfelder | O. Padron | A. Pezzella | A. Shapiro | Margaret G Mueller | C. Taylor | R. Mccrery | M. Perrouin‐Verbe
[1] U. Lee,et al. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique , 2019, Neurourology and urodynamics.
[2] J. Hippisley-Cox,et al. Anticholinergic Drug Exposure and the Risk of Dementia , 2019, JAMA internal medicine.
[3] T. Kessler,et al. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2‐year clinical outcomes and sensory responses to lead stimulation , 2019, BJU international.
[4] B. Blok,et al. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12‐month results from the RELAX‐OAB study , 2019, Neurourology and urodynamics.
[5] B. Blok,et al. Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-month Results of the ARTISAN-SNM Study. , 2019, The Journal of urology.
[6] K. Matzel,et al. International Continence Society best practice statement for use of sacral neuromodulation , 2018, Neurourology and urodynamics.
[7] D. Elterman,et al. The novel Axonics® rechargeable sacral neuromodulation system: Procedural and technical impressions from an initial North American experience , 2018, Neurourology and urodynamics.
[8] K. Matzel,et al. Sacral Neuromodulation: Standardized Electrode Placement Technique , 2017, Neuromodulation : journal of the International Neuromodulation Society.
[9] H. Goldman,et al. Removal of Sacral Nerve Stimulation Devices for Magnetic Resonance Imaging: What Happens Next? , 2017, Neuromodulation : journal of the International Neuromodulation Society.
[10] R. Dmochowski,et al. Cost profiles and budget impact of rechargeable versus non‐rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome , 2017, Neurourology and urodynamics.
[11] M. Hudson,et al. Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues , 2016, Rheumatology.
[12] C. Comiter,et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder , 2016, Neurourology and urodynamics.
[13] H. Akram,et al. Rechargeable occipital nerve stimulator systems: A patient satisfaction study , 2014, British journal of neurosurgery.
[14] Joohi Jimenez-Shahed,et al. Rechargeable Deep Brain Stimulation Implantable Pulse Generators in Movement Disorders: Patient Satisfaction and Conversion Parameters , 2014, Neuromodulation : journal of the International Neuromodulation Society.
[15] Stephanie A. Jacobs,et al. Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet , 2014, Neurourology and urodynamics.
[16] Sean Nicholson,et al. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. , 2014, European urology.
[17] C. Honey,et al. Rechargeable Internal Neural Stimulators—Is There a Problem with Efficacy? , 2012, Neuromodulation : journal of the International Neuromodulation Society.
[18] P. Abrams,et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction , 2011, BJU international.